Arvinder Dhalla
Corporate Officer/Principal at RANI THERAPEUTICS HOLDINGS, INC.
Profile
Arvinder Dhalla is currently working as the Vice President of Clinical Operations at Rani Therapeutics LLC and as the Vice President of Clinical Development at Rani Therapeutics Holdings, Inc. Previously, she worked as the Biology Director of Cardiovascular Therapeutic at Gilead Sciences, Inc. from 2009 to 2015.
Dr. Dhalla holds a doctorate degree from the University of Manitoba and undergraduate and graduate degrees from Panjab University Chandigarh.
Arvinder Dhalla active positions
| Companies | Position | Start |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | - |
Rani Therapeutics LLC
 Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Chief Operating Officer | - |
Former positions of Arvinder Dhalla
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2014-12-31 |
Training of Arvinder Dhalla
| University of Manitoba | Doctorate Degree |
| Panjab University Chandigarh | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| RANI THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Health Technology |
- Stock Market
- Insiders
- Arvinder Dhalla